Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis

Alberto Vogrig, Sarah PCrossed D sign©ricart, Anne Laurie Pinto, VCrossed D.sign©ronique Rogemond, Sergio Muñiz-Castrillo, GCrossed D.sign©raldine Picard, Marion Selton, Michel Mittelbronn, HCrossed D.sign©lène Marie LanoiselCrossed D sign©e, Patrick Michenet, Marie Benaiteau, JCrossed D.sign©r Crossed D.sign©mie Pariente, Helene ZCrossed D sign©phir, Caroline Giordana, Solveig Montaut, Hayet Salhi, Panagiotis Bachoumas, Alexis Montcuquet, Igor Letovanec, Emmanuelle Uro-CosteJCrossed D.sign©rôme Honnorat*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Abstract

In this study, we report the clinical features of Kelch-like protein 11 antibody-associated paraneoplastic neurological syndrome, design and validate a clinical score to facilitate the identification of patients that should be tested for Kelch-like protein 11 antibodies, and examine in detail the nature of the immune response in both the brain and the tumour samples for a better characterization of the immunopathogenesis of this condition. The presence of Kelch-like protein 11 antibodies was retrospectively assessed in patients referred to the French Reference Center for paraneoplastic neurological syndrome and autoimmune encephalitis with (i) antibody-negative paraneoplastic neurological syndrome [limbic encephalitis (n = 105), cerebellar degeneration (n = 33)] and (ii) antibody-positive paraneoplastic neurological syndrome [Ma2-Ab encephalitis (n = 34), antibodies targeting N-methyl-D-aspartate receptor encephalitis with teratoma (n = 49)]. Additionally, since 1 January 2020, patients were prospectively screened for Kelch-like protein 11 antibodies as new usual clinical practice. Overall, Kelch-like protein 11 antibodies were detected in 11 patients [11/11, 100% were male; their median (range) age was 44 (35-79) years], 9 of them from the antibody-negative paraneoplastic neurological syndrome cohort, 1 from the antibody-positive (Ma2-Ab) cohort and 1 additional prospectively detected patient. All patients manifested a cerebellar syndrome, either isolated (4/11, 36%) or part of a multi-system neurological disorder (7/11, 64%). Additional core syndromes were limbic encephalitis (5/11, 45%) and myelitis (2/11, 18%). Severe weight loss (7/11, 64%) and hearing loss/tinnitus (5/11, 45%) were common. Rarer neurologic manifestations included hypersomnia and seizures (2/11, 18%). Two patients presented phenotypes resembling primary neurodegenerative disorders (progressive supranuclear palsy and flail arm syndrome, respectively). An associated cancer was found in 9/11 (82%) patients; it was most commonly (7/9, 78%) a spontaneously regressed ('burned-out') testicular germ cell tumour. A newly designed clinical score (MATCH score: male, ataxia, testicular cancer, hearing alterations) with a cut-off ≥4 successfully identified patients with Kelch-like protein 11 antibodies (sensitivity 78%, specificity 99%). Pathological findings (three testicular tumours, three lymph node metastases of testicular tumours, one brain biopsy) showed the presence of a T-cell inflammation with resulting anti-tumour immunity in the testis and one chronic, exhausted immune response - demonstrated by immune checkpoint expression - in the metastases and the brain. In conclusion, these findings suggest that Kelch-like protein 11 antibody paraneoplastic neurological syndrome is a homogeneous clinical syndrome and its detection can be facilitated using the MATCH score. The pathogenesis is probably T-cell mediated, but the stages of inflammation are different in the testis, metastases and the brain.

Original languageEnglish
Article numberfcab185
JournalBrain communications
Volume3
Issue number3
DOIs
Publication statusPublished - 26 Aug 2021

Keywords

  • antibodies
  • ataxia
  • autoimmune encephalitis
  • immunopathology
  • paraneoplastic neurologic syndrome

Fingerprint

Dive into the research topics of 'Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis'. Together they form a unique fingerprint.

Cite this